COPYRIGHT© Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

COPYRIGHT© 2018  吉林紫鑫药业股份有限公司

Announcement of Jilin Zixin Pharmaceutical Co., Ltd. on the restructuring of the audit institution Zhongzhun Certified Public Ac

Page view

Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Announcement No.: 2013-047

Jilin Zixin Pharmaceutical Co., Ltd.

 

About the audit institution Zhongzhun Certified Public Accountants Co., Ltd.

Renewed announcement

The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.

 

Jilin Zixin Pharmaceutical Co., Ltd. (hereinafter referred to as “the company”) received a letter from the audit institution Zhongzhun Certified Public Accountants Co., Ltd. on December 19, 2013, according to the “Development of the Ministry of Finance and the State Administration for Industry and Commerce on Promoting Large and Medium Accountants”. The firm adopted the Notice of Interim Provisions in the Form of Special General Partnership Organization (Accounting [2010] No. 12), which stipulates that the special general partnership accounting firm will be reformed. At present, Zhongzhun Certified Public Accountants has been approved by the Beijing Municipal Finance Bureau to obtain a practice license, renewed its business license and securities and futures-related business licenses. It has completed the conversion of a special general partnership accounting firm and changed its name to Zhongzhun Certified Public Accountants. (Special General Partnership).

 

In accordance with the "Notice on the Continuation of the Business Qualifications Certified Public Accountants as a Special General Partnership Certified Public Accountant" (Accounting [2012] No. 17), the accounting firm's restructuring and name change are not part of the replacement audit institution, the company does not The board of directors and the general meeting of shareholders are required to consider the matter.

 

Special announcement.

Jilin Zixin Pharmaceutical Co., Ltd. Board of Directors

December 20, 2013